CD163 and metabolic dysfunction-associated steatotic liver disease: From these data, we aimed to investigate the possibility of IL-34, M-CSF, sCD163, MIP-3α/CCL20, hyaluronic acid, type IV collagen 7s, APRI, FIB-4 index, and NFS as a marker of liver fibrosis in NAFLD patients.